Hambleton Julie's Form 4 filing
SpringWorks Therapeutics, Inc. (SWTX) · filed Jun 5, 2024
- Accession no.
- 0001104659-24-068674
- Filed
- Jun 5, 2024
- Trade date
- Jun 3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $186.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hambleton JulieCIK 0001578771 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | Common Stock | SSaleDisposed | −2,946 | $39.41 | −$116,101.86 | 5,797 | Direct | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −751 | $40.57 | −$30,468.07 | 5,046 | Direct | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −931 | $41.49 | −$38,627.19 | 4,115 | Direct | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −20 | $42.09 | −$841.8 | 4,095 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.